Bausch Health Companies Inc. Business Acquisition, Pro Forma Earnings Per Share, Diluted
Bausch Health Companies Inc. (BHC) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of -$1.80 per share for the 12-month period ending 2015-12-31, per its 8-K filed 2018-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2018-08-10
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for the quarter ending 2015-09-30 was $0.16, a 300.00% increase year-over-year.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for the quarter ending 2015-06-30 was -$0.09.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for the quarter ending 2015-03-31 was -$0.78.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for the quarter ending 2014-09-30 was $0.04.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for fiscal 2014 was -$1.09.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for fiscal 2013 was -$2.43.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for fiscal 2012 was -$2.14.
- Bausch Health Companies Inc. business acquisition, pro forma earnings per share, diluted for fiscal 2011 was -$0.14.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | -$1.80 8-K · filed 2018-08-10 | |||||||
| 2015-09-30 | $0.16 10-Q · filed 2016-11-09 | -$0.71 10-Q · filed 2016-11-09 | -$0.75 10-Q · filed 2015-10-26 | |||||
| 2015-06-30 | -$0.09 10-Q · filed 2016-08-09 | -$0.07 10-Q · filed 2015-07-28 | -$0.87 10-Q · filed 2016-08-09 | -$0.96 10-Q · filed 2015-07-28 | ||||
| 2015-03-31 | -$0.78 10-Q · filed 2016-06-07 | $0.27 10-Q · filed 2015-04-30 | ||||||
| 2014-12-31 | -$1.09 10-K · filed 2017-03-01 | $2.66 10-K · filed 2015-02-25 | ||||||
| 2014-09-30 | $0.04 10-Q · filed 2015-10-26 | $0.82 10-Q · filed 2014-10-24 | -$0.99 10-Q · filed 2015-10-26 | $1.10 10-Q · filed 2014-10-24 | ||||
| 2014-06-30 | -$0.15 10-Q · filed 2015-07-28 | $0.37 10-Q · filed 2014-08-01 | -$1.03 10-Q · filed 2015-07-28 | $0.30 10-Q · filed 2014-08-01 | ||||
| 2014-03-31 | -$0.22 10-Q · filed 2015-04-30 | -$0.07 10-Q · filed 2014-05-09 | ||||||
| 2013-12-31 | -$2.43 10-K · filed 2016-04-29 | |||||||
| 2013-09-30 | -$2.72 10-Q · filed 2014-10-24 | -$3.07 10-Q · filed 2014-10-24 | ||||||
| 2013-06-30 | -$0.06 10-Q · filed 2014-08-01 | $0.09 10-Q · filed 2013-08-07 | -$0.31 10-Q · filed 2014-08-01 | $0.10 10-Q · filed 2013-08-07 | ||||
| 2013-03-31 | -$0.25 10-Q · filed 2014-05-09 | |||||||
| 2012-12-31 | -$2.14 10-K · filed 2015-02-25 | -$0.32 10-K · filed 2013-02-28 | ||||||
| 2012-09-30 | $0.04 10-Q · filed 2012-11-05 | $0.03 10-Q · filed 2012-11-05 | ||||||
| 2012-06-30 | -$0.10 10-Q · filed 2013-08-07 | -$0.02 10-Q · filed 2012-08-03 | -$0.26 10-Q · filed 2013-08-07 | -$0.03 10-Q · filed 2012-08-03 | ||||
| 2011-12-31 | -$0.14 10-K · filed 2013-02-28 | $0.47 10-K · filed 2012-02-29 | ||||||
| 2011-09-30 | $0.06 10-Q · filed 2012-11-05 | $0.10 10-Q · filed 2011-11-04 | $0.22 10-Q · filed 2012-11-05 | $0.37 10-Q · filed 2011-11-04 | ||||
| 2011-06-30 | $0.16 10-Q · filed 2012-08-03 | $0.22 10-Q · filed 2011-08-08 | $0.15 10-Q · filed 2012-08-03 | $0.30 10-Q · filed 2011-08-08 | ||||
| 2011-03-31 | $0.04 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | -$1.08 10-K · filed 2012-02-29 | |||||||
| 2010-09-30 | -$0.34 10-Q · filed 2011-11-04 | -$0.55 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$0.02 10-Q · filed 2011-08-08 | -$0.17 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |